Dennis Podlesak - Oct 5, 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Oct 5, 2021
Transactions value $
$0
Form type
4
Date filed
10/6/2021, 04:09 PM
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Other $0 +463 +1.07% $0.00 43.8K Oct 5, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock of the Issuer received from One Palmer Square Associates VIII, L.L.C. through a pro-rata distribution for no consideration.